USPatent applicationPatented

Process for the epoxidation of an organic compound with oxygen or an oxygen-delivering compounds using catalysts containing metal-organic frame-work materials

Granted 23 Sep 2003 · no office action yet

Application· this page
10/157,494
filed 30 May 2002
Publication
Not published
not published
Patent
US 6,624,318
granted 23 Sep 2003

Life of the application

6 dated events
⤢ drag to zoom20022004200620082010201220142016201820202022ProsecutionOwnershipTerm & fees
ProsecutionOwnershipTerm & feeshover for detail · click to open

Abstract

The present invention relates to a process for the reaction of at least one organic compound with one oxygen-delivering substance, for example a hydroperoxide, in the presence of at least one catalyst containing a metal-organic framework material comprising pores and a metal ion and an at least bidentate organic compound, said bidentate organic compound being coordinately bound to the metal ion. Further, the present invention is directed to the products being obtainable by the process according to the invention.

Description

6 parts
›The present invention relates to a process for…

The present invention relates to a process for the epoxidation of at least one organic compound with oxygen or an oxygen-delivering compound, in the presence of at least one catalyst containing a metal-organic framework material comprising pores and a metal ion and an at least bidentate organic compound, said bidentate organic compound being coordinately bound to the metal ion. Further, the present invention is directed to the products being obtainable by the process according to the invention.

Reactions of organic compounds with oxidizing agents as hydroperoxides are well known in the prior art, for example from DE 100 55 652.3 and further patent applications of the present applicant, such as DE 100 32 885.7, DE 100 32 884.9 or DE 100 15 246.5.

The state of the art for catalysts used in epoxidation reactions is given by materials containing zeolites, in particular catalysts which comprise a titanium-, vanadium-, chromium-, niobium- or zirconium-containing zeolite as a porous oxidic material. Such catalysts are described, for example, in WO 00/07965.

In a promising novel and alternative strategy to create micro- and/or mesoporous catalytically active materials, metal ions and molecular organic building blocks are used to form so-called metal-organic frameworks (MOFs). The metal-organic framework materials as such are described, for example, in. U.S. Pat. No. 5,648,508, EP-A-0 709 253, M. O'Keeffe et al., J. Sol. State Chem ., 152 (2000) p. 3-20, H. Li et al., Nature 402 (1999) p. 276 seq., M. Eddaoudi et al., Topics in Catalysis 9 (1999) p. 105-111,B. Chen et al., Science 291 (2001) p. 1021-23. Among the advantages of these novel materials, in particular for applications in catalysis, are the following:

(i) larger pore sizes can be realized than for the zeolites used presently

(ii) the internal surface area is larger than for porous materials used presently

(iii) pore size and/or channel structure can be tailored over a large range

(iv) the organic framework components forming the internal surface can be functionalized easily.

However, these novel porous materials have only been described as such. The use of these catalytically active materials in reactions of technical importance, in particular for epoxidation reactions, has not been disclosed yet.

It is an object of the present invention to provide a catalyst for the reaction of organic compounds with oxygen and/or oxygen-delivering compounds, wherein the catalyst for said reaction contains a novel material, in addition to, or instead of, catalytic materials according to the prior art, particularly in addition to, or instead of, zeolites.

This object is solved by providing a process for the epoxidation of at least one organic compound with oxygen and/or at least one oxygen-delivering compound in the presence of a catalyst, wherein said catalyst contains a metal-organic framework material comprising pores and at least one metal ion and at least one at least bidentate organic compound, which is coordinately bound to said metal ion.

As epoxidation agents, oxygen and oxygen-delivering compounds can be used. This includes but is not limited to ozone, water, oxidizing enzymes, reactive oxides, such as permanganates, chromic oxide, nitric oxide and the like. If oxygen is used, the gas may be mixed with other reactive gases and/or inert gases. Preferred are hydroperoxides known from the prior art which are suitable for the reaction of the organic compound. Mixtures of at least two of the aforementioned epoxidation agents are included as well. The generic formula of a hydroperoxide can be given as R—O—O—H. In principle, any organic or inorganic entity known to the expert in the field may be used as the group “R”. Examples of such hydroperoxides are tertbutyl hydroperoxide, ethylbenzene hydroperoxide, and cumenehydroperoxide. In the present invention, preference is given to using hydrogen peroxide as hydrol peroxide. The present invention therefore also provides a process as described above, in which the hydroperoxide used is hydrogen peroxide. Preference is given to using an aqueous hydrogen peroxide solution. The hydrogen peroxide, or any hydroperoxide for that matter, can be either prepared outside the reaction or by starting from hydrogen and oxygen, or other suitable components, in situ within the reaction.

With respect to epoxidation reactions, DE 100 55 652.3, DE 100 32 885.7, DE 100 32 884.9, DE 100 15 246.5, DE 199 36 547.4, DE 199 26 725.1, DE 198 47 629.9, DE 198 35 907.1, DE 197 23 950.1 are fully encompassed within the content of the present application with respect to their respective content.

Other known processes for epoxidation reactions are not excluded from the present application, and are, for example, described in Weissermel, Arpe “Industrielle Organische Chemie”, publisher VCH, Weinheim, 4 th Ed., pages 288 to 318 and in U. Onken, Anton Behr, “Chemische Prozesskunde”, Vol. 3, Thieme, 1996, pages 303 to 305 as well as Weissernel, Arpe “Industrial Organic Chemistry”, 5 th Ed., Wiley, 1998, pages 159 to 181.

Among the reactions which are possible in the process of the present invention, the following are mentioned by way of example and without limiting the general scope of the present invention:

the epoxidation of olefins, e.g. the preparation of propylene oxide from propylene and H 2 O 2 or from propylene and mixtures which provide H 2 O 2 in situ;

hydroxylations such as the hydroxylation of monocyclic, bicyclic or polycyclic aromatics to give monosubstituted, disubstituted or higher-substituted hydroxyaromatics, for example the reaction of phenol and H 2 O 2 , or of phenol and mixtures which provide H 2 O 2 in situ, to form hydroquinone;

oxime formation from ketones in the presence of H 2 O 2 , or mixtures which provide H 2 O 2 in situ, and ammonia (ammonoximation), for example the preparation of cyclohexanone oxime from cyclohexanone;

the Baeyer-Villiger oxidation.

In the process of the present invention, organic compounds which have at least one C—C double bond are epoxidized.

›Examples of such organic compounds having at least…

Examples of such organic compounds having at least one C—C double bond are the following alkenes: ethene, propene, 1-butene, 2-butene, isobutene, butadiene, pentene, piperylene, hexenes, hexadienes, heptenes, octenes, diisobutene, trimethylpentene, nonenes, dodecene, tridecene, tetradecene to eicosene, tripropene and tetrapropene, polybutadienes, polyisobutenes, isoprenes, terpenes, geraniol, linalool, linalyl acetate, methylenecyclopropane, cyclopentene, cyclohexene, norbornene, cycloheptene, vinylcyclohexane, vinyloxiran, vinylcyclohexene, styrene, cyclooctene, cyclooctadiene, vinylnorbornene, indene, tetrahydroindene, methylstyrene, dicyclopentadiene, dinvinylbenzene, cyclododecene, cyclododecatriene, stilbene, diphenylbutadiene, vitamin A, beta-carotene, vinylidene fluoride, allyl halides, crotyl chloride, methallyl chloride, dichlorobutene, allyl alcohol, methallyl alcohol, butenols, butenediols, cyclopentenediols, pentenols, octadienols, tridecenols, unsaturated steroids, ethoxyethene, isoeugenol, anethole, unsaturated carboxylic acids such as acrylic acid, methacrylic acid, crotonic acid, maleic acid, vinylacetic acid, unsaturated fatty acids such as oleic acid, linoleic acid, palmitic acid, naturally occurring fats and oils.

The process of the present invention is preferably carried out using alkenes having from 2 to 8 carbon atoms. Particular preference is given to reacting ethene, propylene and butene.

As has been mentioned above, metal-organic framework materials as such are described in, for example, U.S. Pat. No. 5,648,508, EP-A-0 709 253, M. O'Keeffe et al., J Sol. State Chem ., 152 (2000) p. 3-20, H. Li et al., Nature 402 (1999) p. 276 seq., M. Eddaoudi et al., Topics in Catalysis 9 (1999) p. 105-111, B. Chen et al., Science 291 (2001) p. 1021-23. An inexpensive way for the preparation of said materials is the subject of DE 10111230.0. The content of these publications, to which reference is made herein, is fully incorporated in the content of the present application.

The catalyst used in the present invention contains at least one of the metal-organic framework material, for example one of the materials described below.

The metal-organic framework materials, as used in the present invention, comprise pores, particularly micro- and/or mesopores. Micropores are defined as being pores having a diameter of 2 nm or below and mesopores as being pores having a diameter in the range of above 2 nm to 50 nm, respectively, according to the definition given in Pure Applied Chem . 45, p. 71 seq., particularly on p. 79 (1976). The presence of the micro- and/or mesopores can be monitored by sorption measurements for determining the capacity of the metal-organic framework materials to take up nitrogen at 77 K according to DIN 66131 and/or DIN 66134.

For example, a type-I-form of the isothermal curve indicates the presence of micropores [see, for example, paragraph 4 of M. Eddaoudi et al., Topics in Catalysis 9 (1999)]. In a preferred embodiment, the specific surface area, as calculated according to the Langmuir model (DIN 66131, 66134) preferably is above 5 m 2 /g, further preferred above 10 m 2 /g, more preferably above 50 m 2 /g, particularly preferred above 500 m 2 /g and may increase into the region of to above 3000 m 2 /g.

As to the metal component within the framework material that is to be used according to the present invention, particularly to be mentioned are the metal ions of the main group elements and of the subgroup elements of the periodic system of the elements, namely of the groups Ia, Ia, IIIa, IVa to VIIIa and Ib to VIb. Among those metal components, particular reference is made to Mg, Ca, Sr, Ba, Sc, Y, Ti, Zr, Hf, V, Nb, Ta, Cr, Mo, W, Mn, Re, Fe, Ru, Os, Co, Rh, Ir, Ni, Pd, Pt, Cu, Ag, Au, Zn, Cd, Hg, Al, Ga, In, Tl, Si, Ge, Sn, Pb, As, Sb, and Bi, more preferably to Zn, Cu, Ni, Pd, Pt, Ru, Rh and Co. As to the metal ions of these elements, particular reference is made to: Mg 2+ , Ca 2+ , Sr 2+ , Ba 2+ , Sc 3+ , Y 3+ , Ti 4+ , Zr 4+ , Hf 4+ , V 4+ , V 3+ , V 2+ , Nb 3+ , Ta 3+ , Cr 3+ , Mo 3+ , W 3+ , Mn 3+ , Mn 2+ , Re 3+ , Re 2+ , Fe 3+ , Fe 2+ , Ru 3+ , Ru 2+ , Os 3+ , Os 2+ , Co 3+ , Co 2+ , Rh 2+ , Rh + , Ir 2+ , Ir + , Ni 2+ , Ni + , Pd 2+ , Pd + , Pt 2+ , Pt + , Cu 2+ , Cu + , Ag + , Au + , Zn 2+ , Cd 2+ , Hg 2+ , Al 3+ , Ga 3+ , In 3+ , Tl 3+ , Si 4+ , Si 2+ , Ge 4+ , Ge 2+ , Sn 4+ , Sn 2+ , Pb 4+ , Pb 2+ , As 5+ , As 3+ , As + , Sb 5+ , Sb 3+ , Sb + , Bi 5+ , Bi 3+ and Bi + .

With regard to the preferred metal ions and further details regarding the same, particular reference is made to: EP-A 0 790 253, particularly to p. 10, 1. 8-30, section “The Metal Ions”, which section is incorporated herein by reference.

In addition to the metal salts disclosed in EP-A 0 790 253 and U.S. Pat. No. 5,648,508, other metallic compounds can be used, such as sulfates, phosphates and other complex counter-ion metal salts of the main- and subgroup metals of the periodic system of the elements. Metal oxides, mixed oxides and mixtures of metal oxides and/or mixed oxides with or without a defined stoichiometry are preferred. All of the above mentioned metal compounds can be soluble or insoluble and they may be used as starting material either in form of a powder or as a shaped body or as any combination thereof.

As to the at least bidentate organic compound, which is capable to coordinate with the metal ion, in principle all compounds can be used which are suitable for this purpose and which fulfill the above requirements of being at least bidentate. Said organic compound must have at least two centers, which are capable to coordinate with the metal ions of a metal salt, particularly with the metals of the aforementioned groups. With regard to the at least bidentate organic compound, specific mention is to be made of compounds having

i) an alkyl group substructure, having from 1 to 10 carbon atoms,

ii) an aryl group substructure, having from 1 to 5 phenyl rings,

iii) an alkyl or aryl amine substructure, consisting of alkyl groups having from 1 to 10 carbon atoms or aryl groups having from 1 to 5 phenyl rings,

›said substructures having bound thereto at least one…

said substructures having bound thereto at least one at least bidentate functional group “X”, which is covalently bound to the substructure of said compound, and wherein X is selected from the group consisting of

CO 2 H, CS 2 H, NO 2 , SO 3 H, Si(OH) 3 , Ge(OH) 3 , Sn(OH) 3 , Si(SH) 4 , Ge(SH) 4 , Sn(SH) 3 , PO 3 H, AsO 3 H, AsO 4 H, P(SH) 3 , As(SH) 3 , CH(RSH) 2 , C(RSH) 3 , CH(RNH 2 ) 2 , C(RNH 2 ) 3 , CH(ROH) 2 , C(ROH) 3 , CH(RCN) 2 , C(RCN) 3 , wherein R is an alkyl group having from 1 to 5 carbon atoms, or an aryl group consisting of 1 to 2 phenyl rings, and CH(SH) 2 , C(SH) 3 , CH(NH 2 ) 2 , C(NH 2 ) 2 , CH(OH) 2 , C(OH) 3 , CH(CN) 2 and C(CN) 3 .

Particularly to be mentioned are substituted or unsubstituted, mono- or polynuclear aromatic di-, tri- and tetracarboxylic acids and substituted or unsubstituted, aromatic, at least one hetero atom comprising aromatic di-, tri- and tetracarboxylic acids, which have one or more nuclei.

A preferred ligand is 1,3,5-benzene tricarboxylate (BCT). Further preferred ligands are ADC (acetylene dicarboxylate), NDC (naphtalen dicarboxylate), BDC (benzene dicarboxylate), ATC (adamantane tetracarboxylate), BTC (benzene tri-carboxylate), BTB (benzene tribenzoate), MTB (methane tetrabenzoate) and ATB (adamantane tribenzoate).

Besides the at least bidentate organic compound, the framework material as used in accordance with the present invention may also comprise one or more mono-dentate ligand(s), which is/are preferably selected from the following mono-dentate substances and/or derivatives thereof:

a. alkyl amines and their corresponding alkyl ammonium salts, containing linear, branched, or cyclic aliphatic groups, having from 1 to 20 carbon atoms (and their corresponding ammonium salts);

b. aryl amines and their corresponding aryl ammonium salts having from 1 to 5 phenyl rings;

c. alkyl phosphonium salts, containing linear, branched, or cyclic aliphatic groups, having from 1 to 20 carbon atoms;

d. aryl phosphonium salts, having from 1 to 5 phenyl rings;

e. alkyl organic acids and the corresponding alkyl organic anions (and salts) containing linear, branched, or cyclic aliphatic groups, having from 1 to 20 carbon atoms;

f. aryl organic acids and their corresponding aryl organic anions and salts, having from 1 to 5 phenyl rings;

g. aliphatic alcohols, containing linear, branched, or cyclic aliphatic groups, having from 1 to 20 carbon atoms;

h. aryl alcohols having from 1 to 5 phenyl rings;

i. inorganic anions from the group consisting of: sulfate, nitrate, nitrite, sulfite, bisulfite, phosphate, hydrogen phosphate, dihydrogen phosphate, diphosphate, triphosphate, phosphite, chloride, chlorate, bromide, bromate, iodide, iodate, carbonate, bicarbonate, and the corresponding acids and salts of the aforementioned inorganic anions,

j. ammonia, carbon dioxide, methane, oxygen, ethylene, hexane, benzene, toluene, xylene, chlorobenzene, nitrobenzene, naphthalene, thiophene, pyridine, acetone, 1-2-dichloroethane, methylenechloride, tetrahydrofuran, ethanolamine, triethylamine and trifluoromethylsulfonic acid.

Further details regarding the at least bidentate organic compounds and the mono-dentate substances, from which the ligands of the framework material as used in the present application are derived, can be taken from EP-A 0 790 253, whose respective content is incorporated into the present application by reference.

Within the present application, framework materials of the kind described herein, which comprise Zn 2+ as a metal ion and ligands derived from terephthalic acid as the bidentate compound, are particularly preferred. Said framework materials are known as MOF-5 in the literature.

Further metal ions and at least bidentate organic compounds and mono-dentate substances, which are respectively useful for the preparation of the framework materials used in the present invention as well as processes for their preparation are particularly disclosed in EP-A 0 790 253, U.S. Pat. No. 5,648,508 and DE 10111230.0.

As solvents, which are particularly useful for the preparation of MOF-5, in addition to the solvents disclosed in the above-referenced literature, dimethyl formamide, diethyl formamide and N-methylpyrollidone, alone, in combination with each other or in combination with other solvents may be used. Within the preparation of the framework materials, particularly within the preparation of MOF-5, the solvents and mother liquors are recycled after crystallization in order to save costs and materials.

The pore sizes of the metal-organic framework can be adjusted by selecting suitable organic ligands and/or bidendate compounds (=linkers). Generally, the larger the linker, the larger the pore size. Any pore size that is still supported by a the metal-organic framework in the absence of a host and at temperatures of at least 200° C. is conceivable. Pore sizes ranging from 0,2 nm to 30 nm are preferred, with pore sizes ranging from 0,3 nm to 3 nm being particularly preferred.

In the following, examples of metal-organic framework materials (MOFs) are given to illustrate the general concept given above. These specific examples, however, are not meant to limit the generality and scope of the present application.

By way of example, a list of metal-organic framework materials already synthesized and characterized is given below. This also includes novel isoreticular metal organic framework materials (IR-MOFs), which may be used in the context of the present application. Such materials having the same framework topology while displaying different pore sizes and crystal densities are described, for example in M. Eddouadi et al., Science 295 (2002) 469, whose respective content is incorporated into the present application by reference

The solvents used are of particular importance for the synthesis of these materials and are therefore mentioned in the table. The values for the cell parameters (angles α, β and γ as well as the spacings a, b and c, given in Angstrom) have been obtained by x-ray diffraction and represent the space group given in the table as well.

›Examples for the synthesis of these materials as…

Examples for the synthesis of these materials as such can, for example, be found in: J. Am. Chem. Soc. 123 (2001) pages 8241ff or in Acc. Chem. Res. 31 (1998) pages 474ff, which are fully encompassed within the content of the present application with respect to their respective content.

The separation of the framework materials, particularly of MOF-5, from the mother liquor of the crystallization may be achieved by procedures known in the art such as solid-liquid separations, centrifugation, extraction, filtration, membrane filtration, cross-flow filtration, flocculation using flocculation adjuvants (non-ionic, cationic and anionic adjuvants) or by the addition of pH shifting additives such as salts, acids or bases, by flotation, as well as by evaporation of the mother liquor at elevated temperature and/or in vacuo and concentrating of the solid. The material obtained in this step is typically a fine powder and cannot be used for most practical applications, e.g. in catalysis, where shaped bodies are required.

The invention is now further described by way of the following examples, which are, however, not meant to limit the scope of the present application.

›EXAMPLE 1

Preparation of a Catalyst According to the Invention

The following materials were used to prepare one catalyst according to the invention, containing MOF-5 as the porous material and Ag as an active metal:

The AgNO 3 (Merck) is dissolved in DEF (diethylformamide) and acetonitrile in a beaker. This clear solution is then added to an autoclave (250 ml volume) which already contains the MOF-5.

The crystallization occurred at 60° C. and within twenty hours. Subsequently, the solution was cooled and the solvent was decanted from the black crystals. Said crystals were washed in chloroforme until the chloroforme almost showed no color anymore. The catalyst was dried in vacuo until no more change in weigth occured. The yield is 4.7 g with a silver content of 15.3% by weight.

›Example 2

Using the Catalyst from Example 1 for the catalysis of epoxidation reactions

In a gas phase flow apparatus (tubular reactor with 9 mm inner diameter, 150 mm reactor length), 500 mg of the catalyst prepared according to Example 1 are filled as a micro fixed bed. A mixture of oxygen, helium and propylene in the volume ratio of 66:24:10 is streamed over the catalyst at a temperature of 220° C. The effluent stream is analyzed by means of gas chromatography.

After a running time of 10 hours, the turnover with respect to propylene is 4.3% with the selectivity with respect to propylene oxide being 8.2%. After 15 hours, a turnover of 3.3% at a selectivity of 10.3% is obtained.

›Tables in the description — 2
Ingredients
molar ratiosSpace
MOF-nM + LSolventsαβγabcGroup
MOF-0Zn(NO 3 ) 2 .6H 2 Oethanol909012016.71116.71114.189P6(3)/Mcm
H 3 (BTC)
MOF-2Zn(NO 3 ) 2 .6H 2 ODMF90102.8906.71815.4912.43P2(1)/n
(0.246 mmol)toluene
H 2 (BDC)
(0.241 mmol)
MOF-3Zn(NO 3 ) 2 .6H 2 ODMF99.72111.11108.49.7269.91110.45P-1
(1.89 mmol)MeOH
H 2 (BDC)
(1.93 mmol)
MOF-4Zn(NO 3 ) 2 .6H 2 Oethanol90909014.72814.72814.728P2(1)3
(1.00 mmol)
H 3 (BTC)
(0.5 mmol)
MOF-5Zn(NO 3 ) 2 .6H 2 ODMF90909025.66925.66925.669Fm-3m
(2.22 mmol)chloro-
H 2 (BDC)benzene
(2.17 mmol)
MOF-38Zn(NO 3 ) 2 .6H 2 ODMF90909020.65720.65717.8414 cm
(0.27 mmol)chloro-
H 3 (BTC)benzene
(0.15 mmol)
MOF-31Zn(NO 3 ) 2 .6H 2 Oethanol90909010.82110.82110.821Pn(-3)m
Zn(ADC) 20.4 mmol
H 2 (ADC)
0.8 mmol
MOF-12Zn(NO 3 ) 2 .6H 2 Oethanol90909015.74516.90718.167Pbca
Zn 2 (ATC)0.3 mmol
H 4 (ATC)
0.15 mmol
MOF-20Zn(NO 3 ) 2 .6H 2 ODMF9092.13908.1316.44412.807P2(1)/c
ZnNDC0.37 mmolchloro-
H 2 NDCbenzene
0.36 mmol
MOF-37Zn(NO 3 ) 2 .6H 2 ODEF72.3883.1684.339.95211.57615.556P-1
0.2 mmolchloro-
H 2 NDCbenzene
0.2 mmol
MOF-8Tb(NO 3 ) 3 .5H 2 ODMSO90115.79019.839.82219.183C2/c
Tb 2 (ADC)0.10 mmolMeOH
H 2 ADC
0.20 mmol
MOF-9Tb(NO 3 ) 3 .5H 2 ODMSO90102.099027.05616.79528.139C2/c
Tb 2 (ADC)0.08 mmol
H 2 ADB
0.12 mmol
MOF-6Tb(NO 3 ) 3 .5H 2 ODMF9091.289017.59919.99610.545P21/c
0.30 mmolMeOH
H 2 (BDC)
0.30 mmol
MOF-7Tb(NO 3 ) 3 .5H 2 OH 2 O102.391.12101.56.14210.06910.096P-1
0.15 mmol
H 2 (BDC)
0.15 mmol
MOF-69AZn(NO 3 ) 2 .6H 2 ODEF90111.69023.1220.9212C2/c
0.083 mmolH 2 O 2
4,4‘BPDCMeNH 2
0.041 mmol
MOF-69BZn(NO 3 ) 2 .6H 2 ODEF9095.39020.1718.5512.16C2/c
0.083 mmolH 2 O 2
2,6-NCDMeNH 2
0.041 mmol
MOF-11Cu(NO 3 ) 2 .2.5H 2 OH 2 O9093.869012.98711.2211.336C2/c
Cu 2 (ATC)0.47 mmol
H 2 ATC
0.22 mmol
MOF-119090908.46718.467114.44P42/mmc
Cu 2 (ATC)
dehydr.
MOF-14Cu(NO 3 ) 2 .2.5H 2 OH 2 O90909026.94626.94626.946Im-3
Cu 3 (BTB)0.28 mmolDMF
H 3 BTBEtOH
0.052 mmol
MOF-32Cd(NO 3 ) 2 .4H 2 OH 2 O90909013.46813.46813.468P(-4)3m
Cd(ATC)0.24 mmolNaOH
H 4 ATC
0.10 mmol
MOF-33ZnCl 2H 2 O90909019.56115.25523.404Imma
Zn 2 (ATB)0.15 mmolDMF
H 4 ATBEtOH
0.02 mmol
MOF-34Ni(NO 3 ) 2 .6H 2 OH 2 O90909010.06611.16319.201P2 1 2 1 2 1
Ni(ATC)0.24 mmolNaOH
H 4 ATC
0.10 mmol
MOF-36Zn(NO 3 ) 2 .4H 2 OH 2 O90909015.74516.90718.167Pbca
Zn 2 (MTB)0.20 mmolDMF
H 4 MTB
0.04 mmol
MOF-39Zn(NO 3 ) 2 4H 2 OH 2 O90909017.15821.59125.308Pnma
Zn 3 O(HBTB)0.27 mmolDMF
H 3 BTBEtOH
0.07 mmol
NO305FeCl 2 .4H 2 ODMF90901208.26928.269263.566R-3c
5.03 mmol
formic acid
86.90 mmol
NO306AFeCl 2 .4H 2 ODEF9090909.936418.37418.374Pbcn
5.03 mmol
formic acid
86.90 mmol
NO29Mn(Ac) 2 .4H 2 ODMF120909014.1633.52133.521P-1
MOF-0 like0.46 mmol
H 3 BTC
0.69 mmol
BPR48Zn(NO 3 ) 2 6H 2 ODMSO90909014.517.0418.02Pbca
A20.012 mmoltoluene
H 2 BDC
0.012 mmol
BPR69Cd(NO 3 ) 2 4H 2 ODMSO9098.769014.1615.7217.66Cc
B10.0212 mmol
H 2 BDC
0.0428 mmol
BPR92Co(NO 3 ) 2 .6H 2 ONMP106.3107.63107.27.530810.94211.025P1
A20.018 mmol
H 2 BDC
0.018 mmol
BPR95Cd(NO 3 ) 2 4H 2 ONMP90112.89014.46011.08515.529P2(1)/n
C50.012 mmol
H 2 BDC
0.36 mmol
CuC 6 H 4 O 6Cu(NO 3 ) 2 .2.5H 2 ODMF90105.299015.25914.81614.13P2(1)/c
0.370 mmolchloro-
H 2 BDC(OH) 2benzene
0.37 mmol
M(BTC)Co(SO 4 )H 2 ODMFSame as MOF-0
MOF-0 like0.055 mmol
H 3 BTC
0.037 mmol
Tb(C 6 H 4 O 6)Tb(NO 3 ) 3 .5H 2 ODMF104.6107.997.14710.49110.98112.541P-1
0.370 mmolchloro-
H 2 (C 6 H 4 O 6 )benzene
0.56 mmol
Zn(C 2 O 4 )ZnCl 2DMF9.0120909.41689.41688.464P(-3)/m
0.370 mmolchloro-
oxalic acidbenzene
0.37 mmol
Co(CHO)Co(NO 3 ) 2 .5H 2 ODMF9091.329011.32810.04914.854P2(1)/n
0.043 mmol
formic acid
1.60 mmol
Cd(CHO)Cd(NO 3 ) 2 .4H 2 ODMF90120908.51688.516822.674R-3c
0.185 mmol
formic acid
0.15 mmol
Cu(C 3 H 2 O 4 )Cu(NO 3 ) 2 .2.5H 2 ODMF9090908.3668.36611.919P43
0.043 mmol
malonic acid
0.192 mmol
Zn 6 (NDC) 5Zn(NO 3 ) 2 .6H 2 ODMF9095.9029019.50416.48214.64C2/m
MOF-480.097 mmolchloro-
14 NDCbenzene
0.069 mmolH 2 O 2
MOF-47Zn(NO 3 ) 2 6H 2 ODMF9092.559011.30316.02917.535P2(1)/c
0.185 mmolchloro-
H 2 (BDC[CH 3 ] 4 )benzene
0.185 mmolH 2 O 2
MO25Cu(NO 3 ) 2 .2.5H 2 ODMF90112.09023.88016.83418.389P2(1)/c
0.084 mmol
BPhDC
0.085 mmol
Cu-ThioCu(NO 3 ) 2 .2.5H 2 ODEF90113.69015.474714.51414.032P2(1)/c
0.084 mmol
thiophene
dicarboxylic
0.085 mmol
ClBDC1Cu(NO 3 ) 2 .2.5H 2 ODMF90105.69014.91115.62218.413C2/c
0.084 mmol
H 2 (BDCCl 2 )
0.085 mmol
MOF-101Cu(NO 3 ) 2 .2.5H 2 ODMF90909021.60720.60720.073Fm3m
0.084 mmol
BrBDC
0.085 mmol
Zn 3 (BTC) 2ZnCl 2DMF90909026.57226.57226.572Fm-3m
0.033 mmolEtOH
H 3 BTCbase
0.033 mmoladded
MOF-jCo(CH 3 CO 2 ) 2 .4H 2 OH 2 O90112.09017.48212.9636.559C2
(1.65 mmol)
H 3 (BZC)
(0.95 mmol)
MOF-nZn(NO 3 ) 2 .6H 2 Oethanol909012016.71116.71114.189P6(3)/mcm
H 3 (BTC)
PbBDCPb(NO 3 ) 2DMF90102.7908.363917.9919.9617P2(1)/n
(0.181 mmol)ethanol
H 2 (BDC)
(0.181 mmol)
ZnhexZn(NO 3 ) 2 .6H 2 ODMF909012037.116537.11730.019P3(1)c
(0.171 mmol)p-xylene
H 3 BTBethanol
(0.114 mmol)
AS16FeBr 2DMF9090.13907.25958.789419.484P2(1)c
0.927 mmolanhydr.
H 2 (BDC)
0.927 mmol
AS27-2FeBr 2DMF90909026.73526.73526.735Fm3m
0.927 mmolanhydr.
H 3 (BDC)
0.464 mmol
AS32FeCl 3DMF909012012.53512.53518.479P6(2)c
1.23 mmolanhydr.
H 2 (BDC)ethanol
1.23 mmol
AS54-3FeBr 2DMF90109.989012.01915.28614.399C2
0.927anhydr.
BPDCn-propanol
0.927 mmol
AS61-4FeBr 2pyridine909012013.01713.01714.896P6(2)c
0.927 mmolanhydr.
m-BDC
0.927 mmol
AS68-7FeBr 2DMF90909018.340710.03618.039Pca2 1
0.927 mmolanhydr.
m-BDCPyridine
1.204 mmol
Zn(ADC)Zn(NO 3 ) 2 .6H 2 ODMF9099.859016.7649.3499.635C2/c
0.37 mmolchloro-
H 2 (ADC)benzene
0.36 mmol
MOF-12Zn(NO 3 ) 2 .6H 2 Oethanol90909015.74516.90718.167Pbca
Zn 2 (ATC)0.30 mmol
H 4 (ATC)
0.15 mmol
MOF-20Zn(NO 3 ) 2 .6H 2 ODMF9092.13908.1316.44412.807P2(1)/c
ZnNDC0.37 mmolchloro-
H 2 NDCbenzene
0.36 mmol
MOF-37Zn(NO 3 ) 2 .6H 2 ODEF72.3883.1684.339.95211.57615.556P-1
0.20 mmolchloro-
H 2 NDCbenzene
0.20 mmol
Zn(NDC)Zn(NO 3 ) 2 .6H 2 ODMSO68.0875.3388.318.63110.20713.114P-1
(DMSO)H 2 NDC
Zn(NDC)Zn(NO 3 ) 2 .6H 2 O9099.29019.28917.62815.052C2/c
H 2 NDC
Zn(HPDC)Zn(NO 3 ) 2 .4H 2 ODMF107.9105.0694.48.32612.08513.767P-1
0.23 mmolH 2 O
H 2 (HPDC)
0.05 mmol
Co(HPDC)Co(NO 3 ) 2 .6H 2 ODMF9097.699029.6779.637.981C2/c
0.21 mmolH 2 O/
H 2 (HPDC)ethanol
0.06 mmol
Zn 3 (PDC)2.5Zn(NO 3 ) 2 .4H 2 ODMF/79.3480.885.838.56414.04626.428P-1
0.17 mmolCIBz
H 2 (HPDC)H 2 O/
0.05 mmolTEA
Cd 2 (TPDC)2Cd(NO 3 ) 2 .4H 2 Omethanol/70.5972.7587.1410.10214.41214.964P-1
0.06 mmolCHP
H 2 (HPDC)H 2 O
0.06 mmol
Tb(PDC)1.5Tb(NO 3 ) 3 .5H 2 ODMF109.8103.61100.149.82912.1114.628P-1
0.21 mmolH 2 O/
H 2 (PDC)ethanol
0.034 mmol
ZnDBPZn(NO 3 ) 2 .6H 2 OMeOH9093.67909.25410.76227.93P2/n
0.05 mmol
dibenzylphosphate
0.10 mmol
Zn 3 (BPDC)ZnBr 2DMF90102.769011.4914.7919.18P21/n
0.021 mmol
4,4‘BPDC
0.005 mmol
CdBDCCd(NO 3 ) 2 .4H 2 ODMF9095.859011.211.1116.71P21/n
0.100 mmolNa 2 SiO 3
H 2 (BDC)(aq)
0.401 mmol
Cd-mBDCCd(NO 3 ) 2 .4H 2 ODMF90101.19013.6918.2514.91C2/c
0.009 mmolMeNH 2
H 2 (mBDC)
0.018 mmol
Zn 4 OBNDCZn(NO 3 ) 2 .6H 2 ODEF90909022.3526.0559.56Fmmm
0.041 mmolMeNH 2
BNDCH 2 O 2
Eu(TCA)Eu(NO 3 ) 3 .6H 2 ODMF90909023.32523.32523.325Pm-3n
0.14 mmolchloro-
TCAbenzene
0.026 mmol
Tb(TCA)Tb(NO 3 ) 3 .6H 2 ODMF90909023.27223.27223.372Pm-3n
0.069 mmolchloro-
TCAbenzene
0.026 mmol
FormateCe(NO 3 ) 3 .6H 2 OH 2 O909012010.66810.6674.107R-3m
0.138 mmolethanol
Formic acid
0.43 mmol
FeCl 2 .4H 2 ODMF90901208.26928.269263.566R-3c
5.03 mmol
Formic acid
86.90 mmol
FeCl 2 .4H 2 ODEF9090909.936418.37418.374Pbcn
5.03 mmol
Formic acid
86.90 mmol
FeCl 2 .4H 2 ODEF9090908.3358.33513.34P-31c
5.03 mmol
Formic acid
86.90 mmol
NO330FeCl 2 .4H 2 Oform-9090908.774911.6558.3297Pnna
0.50 mmolamide
Formic acid
8.69 mmol
NO332FeCl 2 .4H 2 ODIP90909010.031318.80818.355Pbcn
0.50 mmol
Formic acid
8.69 mmol
NO333FeCl 2 .4H 2 ODBF90909045.275423.86112.441Cmcm
0.50 mmol
Formic acid
8.69 mmol
NO335FeCl 2 .4H 2 OCHF9091.3729011.596410.18714.945P21/n
0.50 mmol
Formic acid
8.69 mmol
NO336FeCl 2 .4H 2 OMFA90909011.794548.8438.4136Pbcm
0.50 mmol
Formic acid
8.69 mmol
NO13Mn(Ac) 2 .4H 2 Oethanol90909018.6611.7629.418Pbcn
0.46 mmol
Bezoic acid
0.92 mmol
Bipyridine
0.46 mmol
NO29Mn(Ac) 2 .4H 2 ODMF120909014.1633.52133.521P-1
MOF-0 like0.46 mmol
H 3 BTC
0.69 mmol
Mn(hifac) 2Mn(Ac) 2 .4H 2 Oether9095.32909.57217.16214.041C2/c
(O 2 CC 6 H 5 )0.46 mmol
Hfac
0.92 mmol
Bipyridine
0.46 mmol
BPR43G2Zn(NO 3 ) 2 .6H 2 ODMF9091.379017.966.387.19C2/c
0.0288 mmolCH 3 CN
H 2 BDC
0.0072 mmol
BPR48A2Zn(NO 3 ) 2 6H 2 ODMSO90909014.517.0418.02Pbca
0.012 mmoltoluene
H 2 BDC
0.012 mmol
BPR49B1Zn(NO 3 ) 2 6H 2 ODMSO9091.1729033.1819.82417.884C2/c
0.024 mmolmethanol
H 2 BDC
0.048 mmol
BPR56E1Zn(NO 3 ) 2 6H 2 ODMSO9090.0969014.587314.15317.183P2(1)/n
0.012 mmoln-propanol
H 2 BDC
0.024 mmol
BPR68D10Zn(NO 3 ) 2 6H 2 ODMSO9095.3169010.062710.1716.413P2(1)/c
0.0016 mmolbenzene
H 3 BTC
0.0064 mmol
BPR69B1Cd(NO 3 ) 2 4H 2 ODMSO9098.769014.1615.7217.66Cc
0.0212 mmol
H 2 BDC
0.0428 mmol
BPR73E4Cd(NO 3 ) 2 4H 2 ODMSO9092.324908.72317.056818.438P2(1)/n
0.006 mmoltoluene
H 2 BDC
0.003 mmol
BPR76D5Zn(NO 3 ) 2 6H 2 ODMSO90104.179014.41916.25997.0611Pc
0.0009 mmol
H 2 BzPDC
0.0036 mmol
BPR80B5Cd(NO 3 ) 2 .4H 2 ODMF90115.119028.0499.18417.837C2/c
0.018 mmol
H 2 BDC
0.036 mmol
BPR80H5Cd(NO 3 ) 2 4H 2 ODMF90119.069011.47466.215117.268P2/c
0.027 mmol
H 2 BDC
0.027 mmol
BPR82C6Cd(NO 3 ) 2 4H 2 ODMF9090909.772121.14227.77Fdd2
0.0068 mmol
H 2 BDC
0.202 mmol
BPR86C3Cd(NO 3 ) 2 6H 2 ODMF90909018.344910.03117.983Pca2(1)
0.0025 mmol
H 2 BDC
0.075 mmol
BPR86H6Cd(NO 3 ) 2 .6H 2 ODMF80.9889.6983.4129.875210.26315.362P-1
0.010 mmol
H 2 BDC
0.010 mmol
Co(NO 3 ) 2 6H 2 ONMP106.3107.63107.27.530810.94211.025P1
BPR95A2Zn(NO 3 ) 2 6H 2 ONMP90102.9907.450213.76712.713P2(1)/c
0.012 mmol
H 2 BDC
0.012 mmol
CuC 6 F 4 O 4Cu(NO 3 ) 2 .2.5H 2 ODMF9098.8349010.967524.4322.553P2(1)/n
0.370 mmolchloro-
H 2 BDC(OH) 2benzene
0.37 mmol
Fe FormicFeCl 2 .4H 2 ODMF9091.5439011.4959.96314.48P2(1)/n
0.370 mmol
Formic acid
0.37 mmol
Mg FormicMg(NO 3 ) 2 .6H 2 ODMF9091.3599011.3839.93214.656P2(1)/n
0.370 mmol
Formic acid
0.37 mmol
MgC 6 H 4 O 6Mg(NO 3 ) 2 .6H 2 ODMF9096.6249017.2459.9439.273C2/c
0.370 mmol
H 2 BDC(OH) 2
0.37 mmol
ZnC 2 H 4 BDCZnCl 2DMF9094.714907.338616.83412.52P2(1)/n
MOF-380.44 mmol
CBBDC
0.261 mmol
MOF-49ZnCl 2DMF9093.4599013.50911.98427.039P2/c
0.44 mmolCH3CN
m-BDC
0.261 mmol
MOF-26Cu(NO 3 ) 2 .5H 2 ODMF9095.6079020.879716.01726.176P2(i)/n
0.084 mmol
DCPE
0.085 mmol
MOF-112Cu(NO 3 ) 2 .2.5H 2 ODMF90107.499029.324121.29718.069C2/c
0.084 mmolethanol
o-Br-m-BDC
0.085 mmol
MOF-109Cu(NO 3 ) 2 .2.5H 2 ODMF90111.989023.880116.83418.389P2(1)/c
0.084 mmol
KDB
0.085 mmol
MOF-111Cu(NO 3 ) 2 .2.5H 2 ODMF90102.169010.676718.78121.052C2/c
0.084 mmolethanol
o-BrBDC
0.085 mmol
MOF-110Cu(NO 3 ) 2 .2.5H 2 ODMF909012020.065220.06520.747R-3/m
0.084 mmol
thiophene dicarboxylic
0.085 mmol
MOF-107Cu(NO 3 ) 2 .2.5H 2 ODEF104.897.07595.20611.03218.06718.452P-1
0.084 mmol
thiophene dicarboxylic
0.085 mmol
MOF-108Cu(NO 3 ) 2 .2.5H 2 ODBF/90113.639015.474714.51414.032C2/c
0.084 mmolmethanol
thiophene dicarboxylic
0.085 mmol
MOF-102Cu(NO 3 ) 2 .2.5H 2 ODMF91.63106.24112.019.384510.79410.831P-1
0.084 mmol
H 2 (BDCCl 2 )
0.085 mmol
Clbdc1Cu(NO 3 ) 2 .2.5H 2 ODEF90105.569014.91115.62218.413P-1
0.084 mmol
H 2 (BDCCl 2 )
0.085 mmol
Cu(NMOP)Cu(NO 3 ) 2 2.5H 2 ODMF90102.379014.923818.72715.529P2(1)/m
0.084 mmol
NBDC
0.085 mmol
Tb(BTC)Tb(NO 3 ) 3 .5H 2 ODMF90106.029018.698611.36819.721
0.033 mmol
H 3 BTC
0.033 mmol
Zn 3 (BTC) 2ZnCl 2DMF90909026.57226.57226.572Fm-3m
Honk0.033 mmolethanol
H 3 BTC
0.033 mmol
Zn 4 O(NDC)Zn(NO 3 ) 2 .4H 2 ODMF90909041.559418.81817.574aba
0.066 mmolethanol
14NDC
0.066 mmol
CdTDCCd(NO 3 ) 2 .4H 2 ODMF90909012.17310.4857.33Pmma
0.014 mmolH 2 O
thiophene
0.040 mmol
DABCO
0.020 mmol
IRMOF-2Zn(NO 3 ) 2 .4H 2 ODEF90909025.77225.77225.772Fm-3m
0.160 mmol
o-Br-BDC
0.60 mmol
IRMOF-3Zn(NO 3 ) 2 .4H 2 ODEF90909025.74725.74725.747Fm-3m
0.20 mmolethanol
H 2 N—BDC
0.60 mmol
IRMOF-4Zn(NO 3 ) 2 .4H 2 ODEF90909025.84925.84925.849Fm-3m
0.11 mmol
[C 3 H 7 O] 2 —BDC
0.48 mmol
IRMOF-5Zn(NO 3 ) 2 .4H 2 ODEF90909012.88212.88212.882Pm-3m
0.13 mmol
[C 5 H 11 O] 2 —BDC
0.50 mmol
IRMOF-6Zn(NO 3 ) 2 .4H 2 ODEF90909025.84225.84225.842Fm-3m
0.20 mmol
[C 2 H 4 ]—BDC
0.60 mmol
IRMOF-7Zn(NO 3 ) 2 .4H 2 ODEF90909012.91412.91412.914Pm-3m
0.07 mmol
1,4NDC
0.20 mmol
IRMOF-8Zn(NO 3 ) 2 .4H 2 ODEF90909030.09230.09230.092Fm-3m
0.55 mmol
2,6NDC
0.42 mmol
IRMOF-9Zn(NO 3 ) 2 .4H 2 ODEF90909017.14723.32225.255Pnnm
0.05 mmol
BPDC
0.42 mmol
IRMOF-10Zn(NO 3 ) 2 .4H 2 ODEF90909034.28134.28134.281Fm-3m
0.02 mmol
BPDC
0.012 mmol
IRMOF-11Zn(NO 3 ) 2 .4H 2 ODEF90909024.82224.82256.734R-3m
0.05 mmol
HPDC
0.20 mmol
IRMOF-12Zn(NO 3 ) 2 .4H 2 ODEF90909034.28134.28134.281Fm-3m
0.017 mmol
HPDC
0.12 mmol
IRMOF-13Zn(NO 3 ) 2 .4H 2 ODEF90909024.82224.82256.734R-3m
0.048 mmol
PDC
0.31 mmol
IRMOF-14Zn(NO 3 ) 2 .4H 2 ODEF90909034.38134.38134.381Fm-3m
0.17 mmol
PDC
0.12 mmol
IRMOF-15Zn(NO 3 ) 2 .4H 2 ODEF90909021.45921.45921.459Im-3m
0.063 mmol
TPDC
0.025 mmol
IRMOF-16Zn(NO 3 ) 2 .4H 2 ODEF90909021.4921.4921.49Pm-3m
0.0126 mmolNMP
TPDC
0.05 mmol
ADCAcetylene dicarboxylic acid
NDCNaphtalene dicarboxylic acid
BDCBenzene dicarboxylic acid
ATCAdamantane tetracarboxylic acid
BTCBenzene tricarboxylic acid
BTBBenzene tribenzoate
MTBMethane tetrabenzoate
ATBAdamantane tetrabenzoate
ADBAdamantane dibenzoate
StartingMolar
MaterialAmountCalculatedExperimental
AgNO 325.9mmol4.3g4.4g
DEF904.6mmol91.5g91.5g
MOF-54.2g4.2g
acetontrile33.0g33.0g
4 of 6 part labels are ours — the grant heads the rest

Claims as granted

18 claims

Log in to read the claims of this application.

Log in to unlock

Classifications

9 codes
IPC · International Patent Classification
Section B — Performing operations; transporting
  • B01J31/22
  • B01J31/16
Section C — Chemistry; metallurgy
  • C07D301/10
USPC · US Patent Classification
549/529549/534549/523549/536549/533549/531

Claim changes

Soon
Coming soonHow the claims changed between publication and grant

See which claims were amended, added or cancelled during examination, with every added and removed word marked.

AmendedAddedCancelledUnchanged

The published claims of this application are not paired with the granted ones in what we hold.

File wrapper

⤢ drag to zoomApr 2002Jul 2002Oct 2002Jan 2003Apr 2003Jul 2003Oct 2003USPTOApplicantNotice of allowance
USPTOApplicanthover for detail · click to open
Pendency
1.3 y
481 days filing → grant
Office actions
0
none on record
Examiner
Ba K. Trinh
art unit 1625 · TC 1600
Citations: 5 back · 73 forward

See the full prosecution history — every USPTO and applicant action on this file, in order.

Log in to unlock

Documents

Log in to open the documents of this file: the application as filed, every office action and response, the notice of allowance.

Log in to unlock

Chain of title

⤢ drag to zoom2004200620082010201220142016201820202022Owner 2
Titlehover for detail · click to open

See the full assignment history — every owner this patent has passed through, with recordation dates and reel/frame numbers.

Log in to unlock